Fulminant hepatic failure induced oxidative stress in nonsynaptic mitochondria of cerebral cortex in rats

Neuroscience Letters
P V B ReddyP Reddanna

Abstract

Fulminant hepatic failure (FHF) is a condition with sudden onset of necrosis of hepatocytes and degeneration of liver tissue without any established liver disease. FHF is associated with increased ammonia levels in blood and brain, which is supposed to be neurotoxic, ultimately leading to neuronal death. Evidences from previous studies suggest for mitochondrial dysfunctions under hyperammonemic conditions. In the present investigation, on thioacetamide-induced FHF rat models, studies were undertaken on cerebral nonsynaptic mitochondrial oxidative stress. The results of the present study reveal elevated lipid peroxidation along with reduced total thiol levels in the cerebral cortex mitochondria of experimental animals compared to saline treated control rats. In addition, the enzymatic activities of glutathione peroxidase and glutathione reductase were decreased, with an elevation in Mn-SOD activity. Overall, thioacetamide-induced FHF in rats enhanced the levels of lipid peroxidation coupled with impaired antioxidant defenses in the cerebral nonsynaptic mitochondria.

References

Jun 1, 1979·Analytical Biochemistry·H OhkawaK Yagi
Jul 1, 1979·Physiological Reviews·B ChanceA Boveris
Aug 23, 1976·Biochemical and Biophysical Research Communications·R A Lawrence, R F Burk
Nov 1, 1992·Journal of Neurochemistry·B Halliwell
Oct 1, 1992·Current Opinion in Neurobiology·M F Beal
Mar 1, 1992·Metabolic Brain Disease·V L RaoR F Butterworth
Jul 1, 1991·Neurochemical Research·M D NorenbergJ T Neary
Apr 1, 1987·Physiological Reviews·A J Cooper, F Plum
May 15, 1986·Archives of Biochemistry and Biophysics·I Fridovich
Nov 1, 1971·Analytical Biochemistry·C Beauchamp, I Fridovich
May 1, 1984·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·G PapaevangelouC Richardson
Nov 1, 1994·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·F StaubA Baethmann
Oct 1, 1996·Neurochemical Research·C HermenegildoV Felipo
Oct 1, 1996·Current Opinion in Neurobiology·D W Choi
Aug 1, 1996·Seminars in Liver Disease·M D Norenberg
Feb 10, 1998·Free Radical Research·E KosenkoV Felipo
Feb 20, 1998·Journal of Neuroscience Research·J Albrecht
Jan 23, 1999·Free Radical Biology & Medicine·A J Kowaltowski, A E Vercesi
Mar 17, 1999·Biochimica Et Biophysica Acta·S J HealesJ B Clark
Feb 12, 1999·Metabolic Brain Disease·M D Norenberg
Jul 13, 1999·Free Radical Biology & Medicine·E KosenkoV Felipo
Aug 2, 2000·The American Journal of Clinical Nutrition·C K Sen, L Packer
May 8, 2001·Human & Experimental Toxicology·S Doğru-AbbasoğluM Uysal
Oct 10, 2001·Journal of Neuroscience Research·C R MurthyM D Norenberg
Dec 18, 2001·Journal of Neuroscience Research·G BaiM D Norenberg
Oct 19, 2002·Nutritional Neuroscience·A V Rao, B Balachandran
Jul 30, 2003·Brain Research·Elena KosenkoVicente Felipo

❮ Previous
Next ❯

Citations

May 18, 2005·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Isaac TúnezPedro Montilla
Aug 17, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Ersin FadilliogluMustafa Iraz
Mar 10, 2010·Neurochemistry International·Pichili Vijaya Bhaskar ReddyPaul K Y Wong
Jun 16, 2009·Neurochemistry International·Wenlei JiangRoger F Butterworth
Nov 13, 2008·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Diego Martín RosellóJuan Carlos Perazzo
Aug 29, 2012·Liver International : Official Journal of the International Association for the Study of the Liver·Shi JinXiao-Dong Liu
Jun 29, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Boris GörgDieter Häussinger
Sep 27, 2005·Transplantation Proceedings·O DetryJ Pincemail
Jan 13, 2015·Neurochemistry International·Joanna Ruszkiewicz, Jan Albrecht
Feb 1, 2007·The American Journal of Chinese Medicine·Jianzhu LiuSung-Whan Cho
Feb 9, 2017·Canadian Journal of Physiology and Pharmacology·Rasha E MostafaHanan A Ogaly
Aug 24, 2010·Arquivos de neuro-psiquiatria·Aline Silva de MirandaAntônio Lúcio Teixeira
Jul 12, 2005·Neurochemistry International·Silvia Lores-ArnaizAbraham Lemberg
Jul 14, 2017·Canadian Journal of Physiology and Pharmacology·Angélica S ReisEthel A Wilhelm
Feb 8, 2018·Canadian Journal of Physiology and Pharmacology·Nehal A AfifiMona K Galal
Jul 13, 2011·Liver International : Official Journal of the International Association for the Study of the Liver·Natalia Nieto
Mar 3, 2010·Metabolic Brain Disease·Chantal BemeurRoger F Butterworth
Sep 8, 2007·Metabolic Brain Disease·M D NorenbergK S Panickar
Mar 3, 2010·Metabolic Brain Disease·Xiaoling YangChristopher F Rose
Feb 26, 2014·Metabolic Brain Disease·Kakulavarapu V Rama RaoMichael D Norenberg
Oct 4, 2019·Free Radical Biology & Medicine·Gianluca CatucciSheila J Sadeghi
Nov 26, 2020·Journal of Experimental Pharmacology·Omid FarshadAkram Jamshidzadeh

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.